Tezepelumab as an Emerging Therapeutic Option for the Treatment of Severe Asthma: Evidence to Date

Asthma is a complex heterogeneous disease defined by chronic inflammation of the airways. Patients present with wheezing, chest tightness, cough and shortness of breath. Bronchial hyperresponsiveness and variable expiratory airflow limitation are hallmark features. About 3.6–6.1% of patients, despit...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorey-Stein, Zachariah L, Shenoy, Kartik V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850420/
https://www.ncbi.nlm.nih.gov/pubmed/33536746
http://dx.doi.org/10.2147/DDDT.S250825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850420/
https://www.ncbi.nlm.nih.gov/pubmed/33536746
http://dx.doi.org/10.2147/DDDT.S250825

Ejemplares similares